GLN-APREMILAST
GLENMARK PHARMACEUTICALS CANADA INC.
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is GLN-APREMILAST discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that GLN-APREMILAST 30MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is GLN-APREMILAST not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AURO-APREMILAST
AURO PHARMA INC
JAMP APREMILAST
JAMP PHARMA CORPORATION
PMS-APREMILAST
PHARMASCIENCE INC
SANDOZ APREMILAST
SANDOZ CANADA INCORPORATED
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02518910
Strength
30MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Business reasons
Disruption of the manufacture of the drug.
Other Products from GLENMARK PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02466783
DIN 02462060
DIN 02421437
DIN 02421445
750MG · DIN 02528495
20MG · DIN 02544369
5MG · DIN 02519852
10MG · DIN 02519860
600MG · DIN 02410990
800MG · DIN 02411008
40MG · DIN 02469820
20MG · DIN 02469812